KBL Merger Corp. IV
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $100M
- Underwriters
- Focus
- Healthcare, Wellness
- SEC Filings
- 1690080
- Public Embarc Page
- https://embarc.com/capital/spac/1690080/KBLM/kbl-merger
- IPO Ticker
- KBLM
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and DirectorMarlene Krauss, M.D.
- Chief Operating Officer and DirectorJoseph A. Williamson
- Chairman (Nominee) of the Board of DirectorsGeorge Hornig
- DirectorAndrew Sherman
- DirectorSherrill Neff
Target Information
Information on the SPAC target for merger.
- Company
- 180 Life Sciences
- Presentation
- Investor Presentation (SEC) on 2020-10-13
- Description
- 180 Life Sciences (formerly known as CannBioRx Life Sciences Corp.) operates as a pharmaceutical company. The Company focuses on developing novel pharmaceutical drugs and man-made cannabinoids that target key pathways in inflammatory diseases.